Alkermes plc (ALKS) vs AMNEAL PHARMACEUTICALS, INC. (AMRX)
- Alkermes plc ALKS 41.22 +2.79%
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.18 −0.36%
Alkermes plc and AMNEAL PHARMACEUTICALS, INC. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc and AMNEAL PHARMACEUTICALS, INC. are of similar size ($6.7B and $6.2B). AMNEAL PHARMACEUTICALS, INC. trades at the lower P/E: 38.4× against 102×. Alkermes plc grew revenue faster over the last twelve months: 10.8% against 9.28%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (5.05% vs 3.97%) and the higher return on invested capital (11.1% vs 2.76%). Across the 21 metrics below, AMNEAL PHARMACEUTICALS, INC. leads on 11 and Alkermes plc on 10.
Valuation
Profitability
| Metric | ALKS | AMRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 84.56% | 39.32% | 53.94% |
| Operating margin | 7.03% | 14.56% | 0.00% |
| Net margin | 3.97% | 5.05% | 0.00% |
| Free cash flow margin | 13.35% | (0.37%) | 0.00% |
| Return on equity | 3.85% | (395.84%) | (0.40%) |
| Return on assets | 1.99% | 4.37% | (3.32%) |
| Return on invested capital | 2.76% | 11.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack